Gilead Sciences, Inc. company logo
Gilead Sciences, Inc. logo

Gilead Sciences, Inc. (GILD) EBITDA

Annual EBITDA

$14.58B$1.16B+8.60%

Summary

Current Value
As of today, GILD annual EBITDA is $14.58B, up +8.60% on
Historical Performance
GILD annual EBITDA is up +13.39% over the past 3 years, up +22.29% over the past 5 years
All-Time High Comparison
GILD annual EBITDA is currently -35.73% below its historical high of $22.69B set on
3-Year Low Comparison
GILD annual EBITDA is +17.25% above its 3-year low of $12.44B reached on
Sector Comparison
GILD annual EBITDA is higher than 98.80% of companies in Healthcare sector

EBITDA Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

GILD Performance
MetricDateValue1Y3Y5Y15Y
Annual EBITDA$14.58B+8.6%+13.4%+22.3%+248.9%
Quarterly EBITDA$3.66B+14.3%+10.9%+4.2%+301.8%
TTM EBITDA$14.56B+8.4%+9.6%+25.3%+248.4%
Price$143.90+24.6%+77.5%+122.7%+607.0%
PE Ratio21.22-93.3%-4.8%-97.4%+72.5%
Annual Revenue$29.45B+2.5%+8.7%+19.5%+273.9%
Annual EPS$6.78+1672.8%+86.4%+6861.9%+308.3%
Annual EBIT$11.82B+10.8%+9.8%+13.2%+201.9%
Annual Net Income$8.51B+1672.9%+86.4%+9461.8%+194.5%

EBITDA Highs

GILD Annual EBITDA Highs Comparison
PeriodHighDateCurrent
3Y$14.58Bat high
5Y$14.58Bat high
All$22.69B-35.7%

EBITDA Lows

GILD Annual EBITDA Lows Comparison
PeriodLowDateCurrent
3Y$12.44B+17.3%
5Y$11.92BN/A+22.3%
All-$104.60M>+9999.0%

EBITDA History

YearValueChange
$14.58B+8.6%
$13.43B+8.0%
$12.44B-3.3%
$12.86B+5.0%
$12.25B+2.7%
$11.92B+87.4%
$6.36B-39.6%
$10.54B-32.5%
$15.61B-18.5%
$19.15B-15.6%
$22.69B+38.8%
$16.35B+230.4%
$4.95B+15.9%
$4.27B+2.4%
$4.17B-0.2%
$4.18B+12.3%
$3.72B+33.3%
$2.79B+26.0%
YearValueChange
$2.22B+31.1%
$1.69B+46.3%
$1.16B+76.1%
$656.10M+81.7%
$361.00M+270.5%
$97.44M+193.2%
-$104.60M-162.7%
-$39.81M-1.6%
-$39.18M+45.3%
-$71.57M-67.3%
-$42.78M-35.5%
-$31.58M+16.8%
-$37.98M-40.9%
-$26.95M-62.1%
-$16.63M-215.8%
-$5.27M-31.7%
-$4.00M-

FAQ

  • What is the current annual EBITDA of GILD?

    As of today, GILD annual EBITDA is $14.58B

  • What is 1-year change in GILD annual EBITDA?

    GILD annual EBITDA is up +8.60% year-over-year

  • What is 3-year change in GILD annual EBITDA?

    GILD annual EBITDA is up +13.39% over the past 3 years

  • How far is GILD annual EBITDA from its all-time high?

    GILD annual EBITDA is currently -35.73% below its historical high of $22.69B set on December 31, 2015

  • How does GILD annual EBITDA rank versus sector peers?

    GILD annual EBITDA is higher than 98.80% of companies in Healthcare sector

  • When is GILD next annual earnings release?

    As of today, the next annual earnings release for GILD has not been scheduled

EBITDA Formula

Data Sources & References

  1. GILD Official Website www.gilead.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/882095/000088209526000003/0000882095-26-000003-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/882095/000088209526000003/0000882095-26-000003-index.htm
  4. GILD Profile on Yahoo Finance finance.yahoo.com/quote/GILD
  5. GILD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gild